Lunai Bioworks Inc. Other Comprehensive Income (Loss), Net of Tax
Lunai Bioworks Inc. (LNAI) reported Other Comprehensive Income (Loss), Net of Tax of -$2.87 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2020-05-11
- Lunai Bioworks Inc. other comprehensive income (loss), net of tax for the quarter ending 2019-03-31 was -$2.87M.
- Lunai Bioworks Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-12-31 was -$15.88M.
- Lunai Bioworks Inc. other comprehensive income (loss), net of tax for the quarter ending 2018-09-30 was -$441.60K.
- Lunai Bioworks Inc. other comprehensive income (loss), net of tax for fiscal 2018 was -$6.46M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$2.87M 10-Q · filed 2020-05-11 | -$18.75M derived: sum of 2 quarters · filed 2020-05-11 | -$19.19M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | -$15.88M 10-Q · filed 2020-02-10 | -$16.32M 10-Q · filed 2020-02-10 | ||
| 2018-09-30 | -$441.60K 10-Q · filed 2019-11-13 | |||
| 2018-06-30 | -$6.46M 10-K · filed 2019-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |